These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 518076)

  • 1. Urinary casts as an indicator of renal tubular damage in patients receiving aminoglycosides.
    Schentag JJ; Gengo FM; Plaut ME; Danner D; Mangione A; Jusko WJ
    Antimicrob Agents Chemother; 1979 Oct; 16(4):468-74. PubMed ID: 518076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of renal tubular damage criteria for aminoglycoside nephrotoxicity in critically ill patients.
    Schentag JJ
    J Clin Pharmacol; 1983 Oct; 23(10):473-83. PubMed ID: 6643700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of aminoglycoside nephrotoxicity with urinary beta-2-microglobulin.
    Schentag JJ; Sutfin TA; Plaut ME; Jusko WJ
    J Med; 1978; 9(3):201-10. PubMed ID: 84037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetyl functions and acetate detected by nuclear magnetic resonance spectroscopy of urine to detect renal dysfunction following aminoglycoside and/or glycopeptide antibiotic therapy.
    Racine SX; Le Toumelin P; Adnet F; Cohen Y; Cupa M; Hantz E; Le Moyec L
    Nephron Physiol; 2004; 97(4):p53-7. PubMed ID: 15331932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically ill patients.
    Malacarne P; Bergamasco S; Donadio C
    Chemotherapy; 2006; 52(4):178-84. PubMed ID: 16691027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of urinary beta 2-microglobulin excretion by patients treated with aminoglycosides.
    Schentag JJ; Plaut ME
    Kidney Int; 1980 May; 17(5):654-61. PubMed ID: 6157048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoglycoside-induced nephrotoxicity studied by proton magnetic resonance spectroscopy of urine.
    Tzovaras V; Tsimihodimos V; Kostara C; Mitrogianni Z; Elisaf M
    Nephrol Dial Transplant; 2011 Oct; 26(10):3219-24. PubMed ID: 21372252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubular disorders in low birth weight neonates after prolonged antibiotic treatment.
    Giapros VI; Papadimitriou FK; Andronikou SK
    Neonatology; 2007; 91(2):140-4. PubMed ID: 17344665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients.
    Schentag JJ; Plaut ME; Cerra FB
    Antimicrob Agents Chemother; 1981 May; 19(5):859-66. PubMed ID: 7294770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
    Naruse T; Hirokawa N; Oike S; Maekawa T
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 201 critically ill patients.
    Schentag JJ; Cerra FB; Plaut ME
    Antimicrob Agents Chemother; 1982 May; 21(5):721-6. PubMed ID: 7103453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view.
    Lopez-Novoa JM; Quiros Y; Vicente L; Morales AI; Lopez-Hernandez FJ
    Kidney Int; 2011 Jan; 79(1):33-45. PubMed ID: 20861826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
    Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
    J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal tubular damage without glomerular damage after cytotoxic drugs and aminoglycosides.
    Fleming JJ; Child JA; Cooper EH; Hay AM; Morgan DB; Parapia L
    Biomedicine; 1980 Dec; 33(8):251-4. PubMed ID: 7011432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycoside and glycopeptide renal toxicity in intensive care patients studied by proton magnetic resonance spectroscopy of urine.
    Le Moyec L; Racine S; Le Toumelin P; Adnet F; Larue V; Cohen Y; Leroux Y; Cupa M; Hantz E
    Crit Care Med; 2002 Jun; 30(6):1242-5. PubMed ID: 12072675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The increase in urinary alanine aminopeptidase excretion associated with enflurane anesthesia is increased further by aminoglycosides.
    Motuz DJ; Watson WA; Barlow JC; Velasquez NV; Schentag JJ
    Anesth Analg; 1988 Aug; 67(8):770-4. PubMed ID: 2899408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary alanine aminopeptidase and beta 2-microglobulin as measurements of aminoglycoside-associated renal impairment.
    Trollfors B; Bergmark J; Hiesche K; Jagenburg R
    Infection; 1984; 12(1):20-2. PubMed ID: 6142864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal transport of antibiotics and nephrotoxicity: a review.
    Fanos V; Cataldi L
    J Chemother; 2001 Oct; 13(5):461-72. PubMed ID: 11760211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular nephrotoxicity of aminoglycosides.
    Martínez-Salgado C; López-Hernández FJ; López-Novoa JM
    Toxicol Appl Pharmacol; 2007 Aug; 223(1):86-98. PubMed ID: 17602717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PK/PD modeling of aminoglycoside nephrotoxicity].
    Rougier F; Corvaisier S; Ducher M; Claude D; Jelliffe RW; Maire P
    Pathol Biol (Paris); 2003 Jun; 51(4):234-6. PubMed ID: 12853000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.